Biodexa Pharmaceuticals (BDRX) Other Non-Current Liabilities (2016 - 2022)

Biodexa Pharmaceuticals (BDRX) reported Other Non-Current Liabilities of $242796.2 for Q4 2022, up 260.23% on a YoY basis from $67400.5 in Q4 2021, and up 348.37% sequentially from $54150.5 in Q2 2022.

Biodexa Pharmaceuticals (BDRX) Other Non-Current Liabilities (2016 - 2022) Analysis & Trends

Biodexa Pharmaceuticals (BDRX) has 6 years of Other Non-Current Liabilities data on file, last reported at $242796.2 in Q4 2022.

  • For the quarter ending Q4 2022, Other Non-Current Liabilities rose 260.23% year-over-year to $242796.2; the trailing twelve-month figure through Dec 2022 stood at $242796.2 (up 260.23% YoY), and the FY2022 full-year result was $256185.1, up 272.39% from the prior year.
  • Other Non-Current Liabilities improved to $242796.2 in Q4 2022, from $54150.5 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $242796.2 in Q4 2022 to a low of $54150.5 in Q2 2022.
  • A 5-year average of $131191.2 and a median of $97300.9 in 2019 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities tumbled 47.06% in 2020 and surged 260.23% in 2022, its largest moves.
  • Tracing BDRX's Other Non-Current Liabilities over 5 years: stood at $212316.6 in 2018, then tumbled by 41.26% to $124715.3 in 2019, then plunged by 47.06% to $66022.6 in 2020, then gained by 2.09% to $67400.5 in 2021, then surged by 260.23% to $242796.2 in 2022.
  • Business Quant data shows BDRX's Other Non-Current Liabilities at $242796.2 in Q4 2022, $54150.5 in Q2 2022, and $67400.5 in Q4 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Biodexa Pharmaceuticals 18.43 Bn 18.43 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2022 242,796.16
Jun 30, 2022 54,150.51
Dec 31, 2021 67,400.53
Jun 30, 2021 69,886.41
Dec 31, 2020 66,022.55
Dec 31, 2019 124,715.32
Jun 30, 2019 212,241.58
Dec 31, 2018 212,316.59
Jun 30, 2016 1.15 Mn